XTRA:EUZMedical Equipment
Assessing Eckert & Ziegler (XTRA:EUZ) Valuation After New Thor Medical Lead-212 Collaboration
Eckert & Ziegler (XTRA:EUZ) is back in focus after signing a collaboration and supply agreement with Thor Medical ASA, centered on lead-212 based radiopharmaceutical therapies and future production scale up.
See our latest analysis for Eckert & Ziegler.
The collaboration news arrives after a strong near-term run, with a 9.99% 7-day share price return and a 10.50% 30-day share price return. Over a longer horizon, the 1-year total shareholder return is down 19.19%, while the 3-year total...